vTv Therapeutics Inc (VTVT) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $39.32
• Market Cap: $151.67M
• EPS: $-3.30
• 52-Week High: $44.00
• 52-Week Low: $14.00

Market Sentiment

vTv Therapeutics Inc currently has a Neutral sentiment score of 0.12.

About vTv Therapeutics Inc

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative orally administered small molecule therapies to meet significant unmet medical needs. The company's promising pipeline is primarily focused on treatments for central nervous system disorders and metabolic diseases, underscoring its commitment to advancing healthcare solutions. With a highly experienced management team and strategic collaborations, vTv Therapeutics is st...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for vTv Therapeutics Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does VTVT pay dividends?

vTv Therapeutics Inc (VTVT) does not currently pay a regular dividend.

What is VTVT's market cap?

vTv Therapeutics Inc (VTVT) has a market capitalization of $151.67M with a current stock price of $39.32.